Skip to main content

Table 3 Hazard ratios (HR) with 95% confidence intervals (CI) for the relative risk of death. Cardiovascular disease (CVD) mortality and all-cause mortality in individuals with type 2 diabetes (T2D) compared to those without in each cohort

From: Similar decline in mortality rate of older persons with and without type 2 diabetes between 1993 and 2004 the Icelandic population-based Reykjavik and AGES-Reykjavik cohort studies

 

Adjusted for age and sex

Adjusted for age, sex, and CVD risk factorsa

Adjusted for age, sex, CVD risk factorsa, surgical interventionb, HTNmed.c

Adjusted for age, sex, CVD risk factors a, surgical interventionb, HTNmed.cand statin use

 

HR

95% CI

HR

95% CI

HR

95% CI

HR

95% CI

Death from CVD

        

Reykjavik Study: with T2D vs. without T2D

2.21

1.46-3.34

1.88

1.24-2.85

1.89

1.25-2.87

1.89

1.24-2.86

AGES-Reykjavik: with T2D vs. without T2D

1.69

1.30-2.20

1.46

1.11-1.91

1.46

1.12-1.92

1.47

1.12-1.93

Death from all causes

        

Reykjavik Study: with T2D vs. without T2D

1.66

1.23-2.25

1.55

1.14-2.11

1.56

1.15-2.11

1.54

1.13-2.09

AGES-Reykjavik: with T2D vs. without T2D

1.47

1.23-1.75

1.38

1.15-1.65

1.38

1.15-1.65

1.39

1.16-1.67

  1. aCVD risk factors: total cholesterol, HDL cholesterol, systolic blood pressure, BMI, triglycerides and smoking history.
  2. bSurgical intervention: percutaneous coronary intervention and coronary-artery bypass grafting.
  3. cHTNmed: hypertensive medication.